Solazyme Surges 15% in Nasdaq Debut on Alternative Fuels Bet

Solazyme Inc., the developer of oil products from genetically modified algae, jumped 15 percent in its first day of trading on increasing demand for renewable sources of fuel and specialty chemicals. [...] A key question, [Pavel Molchanov, an analyst for Raymond James & Associates Inc.] said, is whether Solazyme, or rivals that are developing similar products such as Gevo Inc., and Amyris Inc., can do so cost-effectively.

Bron: Bloomberg, May 27 2011